News FDA approves new treatment for rare genetic disease PKU Novel enzyme therapy will treat adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment.
Partner Content Partner Content Wellcome Genome Campus Hackathon 2-3 July Sign up now for the Wellcome Genome Campus Hackathon
Partner Content Partner Content The Microbiome Movement – Skin Health & Dermatology Summ... Join The Microbiome Movement
News Solomon quits as Akari CEO following credit card probe Biotech veteran quits after less than a year in charge
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
